Search

Search Constraints

You searched for: Author/Creator Halford, Jason C G

Search Results

1. A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol. Issue 7 (20th July 2021)

2. Association of Sugar-Sweetened Beverages, Low/No-Calorie Beverages and Fruit Juice Intakes with Non-alcoholic Fatty Liver Disease: The SWEET Project. (14th June 2022)

3. Association of Sugar-Sweetened Beverages, Low/No-Calorie Beverages and Fruit Juice Intakes with Non-alcoholic Fatty Liver Disease: The SWEET Project. (14th June 2022)

5. Circulating metabolites associated with objectively measured sleep duration and sleep variability in overweight/obese participants: a metabolomics approach within the SATIN study. Issue 5 (5th February 2019)

6. Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: a randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)—study protocol. Issue 1 (27th January 2017)

7. Effectiveness and cost-effectiveness of referral to a commercial open group behavioural weight management programme in adults with overweight and obesity: 5-year follow-up of the WRAP randomised controlled trial. (October 2022)

8. Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial. Issue 10085 (3rd June 2017)

9. Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases. (September 2021)

10. Protocol for a multicentre, parallel, randomised, controlled trial on the effect of sweeteners and sweetness enhancers on health, obesity and safety in overweight adults and children: the SWEET project. Issue 10 (12th October 2022)